-+ 0.00%
-+ 0.00%
-+ 0.00%

Intensity Therapeutics Q3 EPS $(1.09) Misses $(0.99) Estimate. Cash and Equivalents $8.5M

Benzinga·11/05/2026 12:42:29
Listen to the news
Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.99) by 10.1 percent. This is a 172.67 percent decrease over earnings of $1.50 per share from the same period last year.